Life Sciences
Asia-Pacific Guide 2025 : Asia-Pacific Region
Band 2
Email address
[email protected]Contact number
+1 202 879 3939Chambers Review
Jones Day fields a talented group distinguished for the scope of its expertise. It handles a range of M&A for pharmaceutical corporate and start-ups in addition to advising on licensing matters and regulatory compliance. The firm is also proficient in liaising between its offices in dealing with the protection and enforcement of IP assets, especially patents. It is additionally proficient in international arbitration relating to this sector. It leverages its global network to assist clients with international matters and often works in conjunction with US-based teams.
Tony Chen in Shanghai and Benjamin Lang in Tokyo are key contacts for the firm.
Work Highlights
- Jones Day advised Sumitomo Pharma on the acquisition of assets from Nabriva Therapeutics and various wholly-owned subsidiaries, in support of the development, manufacturing, marketing and commercialisation of lefamulin in the Greater China Region.
Strengths
Provided by Chambers
"The Jones Day team is easy to work with and seamlessly works across regions utilising experts worldwide."
"Having seen a variety of scenarios, the senior advisers can provide real world experience and examples to help clients make educated decisions and strategy choices."
"The Jones Day team is easy to work with and seamlessly works across regions utilising experts worldwide."
"Having seen a variety of scenarios, the senior advisers can provide real world experience and examples to help clients make educated decisions and strategy choices."